These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24244161)

  • 1. Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II.
    Varney KM; Bonvin AM; Pazgier M; Malin J; Yu W; Ateh E; Oashi T; Lu W; Huang J; Diepeveen-de Buin M; Bryant J; Breukink E; Mackerell AD; de Leeuw EP
    PLoS Pathog; 2013; 9(11):e1003732. PubMed ID: 24244161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity exploration of a small-molecule Lipid II inhibitor.
    Fletcher S; Yu W; Huang J; Kwasny SM; Chauhan J; Opperman TJ; MacKerell AD; de Leeuw E
    Drug Des Devel Ther; 2015; 9():2383-94. PubMed ID: 25987836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.
    Schmitt P; Wilmes M; Pugnière M; Aumelas A; Bachère E; Sahl HG; Schneider T; Destoumieux-Garzón D
    J Biol Chem; 2010 Sep; 285(38):29208-16. PubMed ID: 20605792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Insights into the Mode of Action of the Peptide Antibiotic Copsin.
    Franzoi M; van Heuvel Y; Thomann S; Schürch N; Kallio PT; Venier P; Essig A
    Biochemistry; 2017 Sep; 56(37):4992-5001. PubMed ID: 28825809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intimate link between antimicrobial peptide sequence diversity and binding to essential components of bacterial membranes.
    Schmitt P; Rosa RD; Destoumieux-Garzón D
    Biochim Biophys Acta; 2016 May; 1858(5):958-70. PubMed ID: 26498397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human defensin-inspired discovery of peptidomimetic antibiotics.
    Luo G; Zhang J; Wang H; Sun Y; Cheng B; Xu Z; Zhang Y; Li H; Lu W; Nemeth E; Ganz T; Fang X
    Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2117283119. PubMed ID: 35238683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
    Oppedijk SF; Martin NI; Breukink E
    Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II.
    de Leeuw E; Li C; Zeng P; Li C; Diepeveen-de Buin M; Lu WY; Breukink E; Lu W
    FEBS Lett; 2010 Apr; 584(8):1543-8. PubMed ID: 20214904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.
    Schneider T; Kruse T; Wimmer R; Wiedemann I; Sass V; Pag U; Jansen A; Nielsen AK; Mygind PH; Raventós DS; Neve S; Ravn B; Bonvin AM; De Maria L; Andersen AS; Gammelgaard LK; Sahl HG; Kristensen HH
    Science; 2010 May; 328(5982):1168-72. PubMed ID: 20508130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eurocin, a new fungal defensin: structure, lipid binding, and its mode of action.
    Oeemig JS; Lynggaard C; Knudsen DH; Hansen FT; Nørgaard KD; Schneider T; Vad BS; Sandvang DH; Nielsen LA; Neve S; Kristensen HH; Sahl HG; Otzen DE; Wimmer R
    J Biol Chem; 2012 Dec; 287(50):42361-72. PubMed ID: 23093408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.
    Chiorean S; Antwi I; Carney DW; Kotsogianni I; Giltrap AM; Alexander FM; Cochrane SA; Payne RJ; Martin NI; Henninot A; Vederas JC
    Chembiochem; 2020 Mar; 21(6):789-792. PubMed ID: 31552694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
    Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
    Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
    Schneider T; Sahl HG
    Curr Opin Investig Drugs; 2010 Feb; 11(2):157-64. PubMed ID: 20112165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting bactoprenol-coupled cell envelope precursors.
    Ulm H; Schneider T
    Appl Microbiol Biotechnol; 2016 Sep; 100(18):7815-25. PubMed ID: 27495122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Found Hope for Antibiotic Discovery: Lipid II Inhibitors.
    Ng V; Chan WC
    Chemistry; 2016 Aug; 22(36):12606-16. PubMed ID: 27388768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II.
    Lunde CS; Hartouni SR; Janc JW; Mammen M; Humphrey PP; Benton BM
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3375-83. PubMed ID: 19470513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of a small-molecule Lipid II binder.
    Chauhan J; Kwasny SM; Fletcher S; Opperman TJ; de Leeuw EPH
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1849-1853. PubMed ID: 31126852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing Equipotent Teixobactin Analogues against Drug-Resistant Bacteria and Discovering a Hydrophobic Interaction between Lipid II and Teixobactin.
    Zong Y; Sun X; Gao H; Meyer KJ; Lewis K; Rao Y
    J Med Chem; 2018 Apr; 61(8):3409-3421. PubMed ID: 29629769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of a Benzothiazole Indolene Scaffold Targeting Bacterial Cell Wall Assembly.
    Chauhan J; Yu W; Cardinale S; Opperman TJ; MacKerell AD; Fletcher S; de Leeuw EP
    Drug Des Devel Ther; 2020; 14():567-574. PubMed ID: 32103898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational evaluation of modified peptides from human neutrophil peptide 1 (HNP-1).
    Moazzezy N; Rismani E; Rezaei M; Karam MRA; Rafati S; Bouzari S; Oloomi M
    J Biomol Struct Dyn; 2022 Feb; 40(3):1163-1171. PubMed ID: 32981420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.